And at the moment, there is the balance in Hatch-Waxman and then there is the balance in the Orphan Drug Act and we are trying to move forward in rare diseases.
Editor's note · Context
Lance discusses the need for balance in drug legislation for rare diseases.
Share & report
More from Leonard Lance
Regardless of your opinion on the 2015 internet rules, I think there is at least one matter on which we should be able to agree, that a legislative fix is preferable to the ping-ponging we have seen play out recently at the FCC.
Our prayers are with the victims of the terrorist attack in New York yesterday, the worst loss of life in such an attack since 9/11.
I commend the chair and the members of the subcommittee on both sides of the aisle on the impressive package of broadband infrastructure bills we are considering today.
Might I respectfully request of you, Mr. Zuckerberg, that you and your company review the BROWSER legislation?





